Literature DB >> 29888576

[Acupoint Injection at "Yingxiang"(LI 20) and "Yintang"(GV 29) May Relieve Nasal Allergic Symptoms Possibly by Down-regulating Expression of Histamine Receptor H 1 and H 4 in Nasal Mucosa of Allergic Rhinitis Rats].

Fei-Hong Liang1, Xun-Rui Hou2, Li-Hong Li1, Xin Liang2, Yu-Wei Lu1, Hong Yang2, Yuan Zhang1.   

Abstract

OBJECTIVE: To observe the effect of acupoint injection at "Yingxiang"(LI 20) and "Yintang"(GV 29) on nasal allergic reactions and the expression of histamine receptor H 1 and H 4 in nasal mucosa of allergic rhinitis (AR) rats, so as to reveal its mechanism underlying improvement of AR.
METHODS: SD rats were randomized into normal, model, non-acupoint injection and acupoint injection groups (n=8 in each). The AR model was established by intraperitoneal (i.p.) injection of mixture of ovalbumin, aluminium hydroxide gel and normal saline (once every other day, for 7 times), and nasal drip of ovalbumin (on the following day of i.p.for 7 days). The mixture solution of lidocaine, dexamethasone (DXM) and transfer factor (0.1 mL/acupoint or non-acupoint) was injected into bilateral LI 20 and GV 29 in the acupoint injection group, or into the non-acupoints (about 5 cm below the armpit on both sides, and the middle point between the left "Houhai"[GV 1] and "Huantiao"[GB 30]), on the 1st , 5th, 9th, and 13th day after modeling. Symptoms of sneezing, nasal discharge, nose-rubbing, etc. were scored after the treatment. The expression levels of H1 R and H4 R proteins and genes in the nasal mucosa tissue were determined using immunohistochemistry and quantitative real-time PCR, respectively.
RESULTS: Compared with the normal group, the symptom score and the expression levels of H1 R, H4 R proteins and genes in nasal mucosa were significantly increased in the model group (P<0.05). After acupoint injection for 4 times, the symptom score and the expression levels of H1 R, H4 R proteins and mRNAs were significantly down-regulated in the acupoint injection group relevant to the model group (P<0.05). There were no significant differences between the non-acupoint and the model groups in the abovementioned indexes (P>0.05), suggesting a specificity of the effect of acupoint injection.
CONCLUSION: Acupoint injection can relieve the allergic symptoms of AR rats, which may be related to its effects in down-regulating the over expression of H1 R and H4 R proteins and genes in the nasal mucosa.

Entities:  

Keywords:  Acupoint injection; Allergic rhinitis; Histamine H 1 receptor; Histamine H 4 receptor; Nasal allergic symptoms

Mesh:

Substances:

Year:  2018        PMID: 29888576     DOI: 10.13702/j.1000-0607.170791

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  3 in total

1.  Acupressure in patients with seasonal allergic rhinitis: a randomized controlled exploratory trial.

Authors:  Miriam Ortiz; Benno Brinkhaus; Lukas Israel; Gabriele Rotter; Ulrike Förster-Ruhrmann; Josef Hummelsberger; Rainer Nögel; Andreas Michalsen; Tatjana Tissen-Diabaté; Sylvia Binting; Thomas Reinhold
Journal:  Chin Med       Date:  2021-12-18       Impact factor: 5.455

2.  The effectiveness and safety of acupuncture for allergic rhinitis: Protocol for an overview of systematic reviews and meta-analyses.

Authors:  Jun Yang; Jun Xiong; Xue Wang; Ting Yuan; Yong Fu; Yunfeng Jiang; Xiaohong Zhou; Kai Liao; Lingling Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

3.  Efficacy and safety of acupoint injection therapy for allergic rhinitis: A protocol for systematic review and meta-analysis.

Authors:  Zhenfeng Chen; Shasha Xing; Yingzhuan Huang; Qifeng Zeng; Donghan Xu; Qiumei He; Huangguan Qin; Xiaofan Luo; Renfeng Li
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.